Health Care & Life Sciences » Biotechnology | Genscript Biotech Corp.

Genscript Biotech Corp. | Ownership

Companies that own Genscript Biotech Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
24,465,023
1.33%
1,318,000
0%
07/31/2018
BlackRock Fund Advisors
14,558,000
0.79%
0
0%
09/06/2018
Matthews International Capital Management LLC
6,524,000
0.36%
824,000
0.04%
06/30/2018
Fisher Asset Management LLC
6,438,000
0.35%
196,000
0.02%
06/30/2018
BlackRock Advisors (UK) Ltd.
2,809,236
0.15%
0
0%
09/06/2018
Dimensional Fund Advisors LP
2,418,000
0.13%
302,000
0%
04/30/2018
SSgA Funds Management, Inc.
1,496,000
0.08%
26,000
0%
09/06/2018
Sjunde AP-fonden
1,390,000
0.08%
1,390,000
0.01%
06/29/2018
Geode Capital Management LLC
1,212,000
0.07%
32,000
0%
09/11/2018
Charles Schwab Investment Management, Inc.
921,505
0.05%
0
0%
09/06/2018

About Genscript Biotech

View Profile
Address
No. 28, Yongxi Road
Nanjing Jiangsu 210000
China
Employees -
Website http://www.genscript.com
Updated 07/08/2019
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services.